Effect of Phototherapy and Urocanic Acid Isomers on Natural Killer Cell Function  by Gilmour, Jill W et al.
Effect of Phototherapy and Urocanic Acid Isomers 
on Natural Killer Cell Function 
Jill W . Gilmour,* James P. Vestey,-" Sheru George,* and Mary Norval* 
'Department of Medical Microbiology, University of Edinburgh Medical School; t University Department of Dermatology, 
Royal Infirmary, Edinburgh; and t Photobiology Unit, Ninewells Hospital, University of Dundee, Scotland 
Ultraviolet (UV) radiation suppresses a variety of immune 
responses but it is uncertain whether this action contributes 
to the effectiveness of phototherapy. Urocanic acid (UCA) 
has been proposed as a m ediator of the immunologic effects 
of UV. On exposure the naturall y occurring trans-isomer of 
UCA in the skin changes into the cis-isomer, which has been 
demonstrated to mimic m any of the immunomodulatory ef-
fec ts of UV irradiation. Natural kill e r (NK) cells play an 
important role in several immunologic processes and pub-
lished evidence indicates that their activity is altered by UV 
irradiation. To ascertain the effect on NK cells of photother-
apy used in the treatment of psoriasis, modulation of NK 
activity in psoriatic patients undergoing broad-band UVB, 
narrow-band UVB, or psoralen plus (PUV A) regimens was 
examined . This was compared with NK cell activity in psori-
atic patients treated with topical coal tar and in normal sub-
jects receiving broad band UVB. 
N atural kill er (NK) cells represent a heterogeneous population oflarge granul ar lymphocytes that have not been assigned to a single lineage or distinct anatomical location of maturation, and tend to be defined on a functional basis. The majority of NK 
ce lls in human peripheral blood are CD56+ CD I6+ CD2+ CDllb+ 
CD3-; other markers, such as CD57, are only expressed on certain 
NK subsets [1 J. They are cytotoxic cells that detect and lyse target 
cells in a non-major histocompatibility complex (MHC) restricted 
manner, although MHC class I allel es have been implicated recently 
in ta rget-cell recognition [2J. 
There is evidence that NK cells playa substantial role in a number 
of immunologic processes. These functions include cytotoxic ac tion 
against tumor cells and virally infected cells [3] and resistance to 
some bacterial, fungal and parasitic agents [4 ,5J. In addition they 
may be involved in rej ection of allogeneic grafts [6J, and in immune 
regulation through the secretion of a number of cytokines [7,8J. 
The receptors involved in target cell recognition by NK cells or the 
signal-transd uction mechanism responsible for effector-cell activa-
tio n remain largely undefined. 
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The NK cell activity of psoriatic and normal subj ects was 
the same over a wide range of effector to target cell ratios. 
Almost all patients undergoing phototherapy exhibited de-
pressed NK cell activity during or after irradiation, a lthough 
the timing of the depression varied between the lamps used 
and may be related to dose. However, patients treated with 
topical coal tar showed unchanged NK cell activity through-
out the therapy. The effect of UCA isom ers on NK cell 
activity in Il itro was also determined. It was found that cis-
UCA induced a dose-dependent suppression of NK cell ac-
tivity in both patients and normal subj ects, whereas tra/u-
UCA had hardly any effect in either group. 
Thus it is possible that there m ay be a correlation between 
cis-UCA formation in the epidermis and the modulation of 
NK cell activity that occurs during phototherapy. Key 
words: UV irradiation/psorias is/ cis-urocanic acid. ] Inllest 
DermatoI101 :169-174, 1993 
In addition to the well-recognized association between it/Ilivo UV 
exposure and the incidence of squamous cel l carcinomas, a number 
of experimental models show that UV irradiation results in tran-
sient suppression of immune responses to antigens that are encoun-
tered shortly thereafter. These include systems where NK cell ac-
tivi ty is thought to be important in immunity, such as infections 
with herpes simplex virus (HSV) [9J and murine acqui red immuno-
defi ciency virus [10], tumor development [11 J; and allograft rejec-
tion. It is of interest that iI/vitro UV irradiation of human peripheral 
blood mononuclear cells (PBMe) results in dose-dependent sup-
pression of NK cell activi ty [12 - 15J. In addition, there is an indica-
tion that exposure to UV and PUVA i/l "ivo may result in suppressed 
NK cell activity [16, 17J . Urocanic acid (UCA), found in the stratum 
corneum, has been proposed as a photoreceptor and mediator of the 
immunomodulatory effects of uV radiation [1 8]. On UV exposure, 
the natura ll y occurring trans-isomer of UCA undergoes a dose-
dependent isomerization to cis-UCA that has been shown to 
mimic many of the effects of UV on the immune system (reviewed 
in [1 9]). 
Psoriasis is a common, geneticall y determined, hyperproliferative 
skin disorder in which the immune system is thought to playa 
critica l role [20,21 J. UVB phototherapy and PUVA are successfully 
employed in the management of psoriasis. However, their use is 
largely empirical and littl e is known of their mechanisms of action 
or of their possible effects on the immune system. Conventional 
broad-band UV sources, such as Sylvania UV6 tubes, emit wave-
lengths from 270 to 370 nm. Wavelengths less than 300 11m are 
highly erythemogenic and, in common with those over 315 nm, are 
relatively ineffective therapeutically [22,23J. Therefore a narrow-
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Table I. Clinical Details of All Subjects Taking Part in the Study 
Number of Mean Age 
Group Patients Age Range Sex Skin Therapy 
A 5 41 19-61 IM/4F Psoriasis Coal Tar 
B 6 37 31-45 4M/2P Psoriasis UVB 
C 6 48 38-73 2M/4F Psoriasis TLOl 
D 6 60 45-72 6M Psoriasis PUVA 
E 7 33 21-52 2M/SF Normal Nil 
F 4 38 32-53 2M/2F Normal UVB 
' N/ A. not applicable . 
band (311-313 11m) source was developed (Philips TL01)§ which 
has proved effective in the management of psoriasis [24,25). 
In the present study the NK cell activities of normal subjects and 
patients with psoriasis were measured . Secondly the effect of thera-
peutic regimellS employing UV6, TL01, or PUVA therapy on NK 
cell act ivity in patients with psoriasis was examined; this was com-
pared with the effect of coal tar therapy in psoriatic patients and 
with a course ofUV6 irradiation in normal subjects. Finally, modu-
lation of NK cell activity in psoriatic patients and normal subjects by 
UCA isomers ill Ililro was determined. 
MATERJALS AND METHODS 
Patients Details of patients and normal subjects are summarized in Table 
I. Groups A, B, E, and F attended the Department of Detmatology, Royal 
Infirmary of Edinburgh; groups C and D attended the Photobiology Unit, 
Ninewclls Hospital, Dundee. All subjects were in good general health and 
taking no other photoactive or immunosuppressive medication. Those with 
psoriasis had chronic plague psoriasis except for three patients in group C 
who had guttate psorias is. Liguid paraffin/white soft paraffin (50/50) or 
emulsifying ointment were used as emol lien ts berween treatments by all 
psoriatic patients including group A. 
Thirty milliliters of venous blood was collected into preservative-free 
heparin in tbe earl y morning. Samples were taken from subjects receiving 
UV -based therapy (groups B, C, 0, and F) immediately before treatment 
starred, after 4 weeks of thcrapy, and 4 weeks aftcr the last irradiation. Group 
A patients were treated with increasing concentrations (1-4%) of topical 
coal tar paste under stockinette dressings. Samples were taken from them 
before treatment commenced and after 4 weeks of therapy. Group E con-
sisted of normal subjects who received no therapy: samples were taken from 
four of this group on rwo occasions, 4 weeks apart. 
UV Irradiation All subjects were of skin types Il or III . Those in group B 
received thc UVB regimen normally used for treatment of psoriasis in Edin-
burgh. They were irradiated in a Waldmann 1000 UVB cabinet containing 
26 Sylvania UV6 tubes emitting 42% in the UVA waveband, 57.6% in 
UVB, and approximately 0.3% in UVC. Irradiance of the tubes was mea-
sured using a filtered photodiode meter [26], which was calibrated against a 
spectroradiometer (model 742, Optrollic Lab Inc). and the total output 
(250 -400 nm) was 1.4 mW cm- 2 • Patients were irradiated with incremen-
tal doses starting with 37 mJ cm- 2, thrice weekly until clear (4-6 weeks). 
Those in group F were normal volunteers who received the same regimen 
for 6 weeks except that only their arms were exposed and the remainder of 
thcir bodies were draped. 
Group C patients had their minimal erytbema doses (MED) determincd 
and an initial dose of 70% of MED was given. They were treated 3 times 
weekly and at each visit the irradiation dose was increased by 40%; the 
increment was reduced or omitted depending on the occurrence and severity 
of erythema. Treatment was stopped when psoriatic plaques had resolved to 
the point of impalpability over all affected sites, excepting minimal residual 
activity 011 knees or elbows (15 -20 treatments). The irradiation, was given 
in an upright cubicle incorporating 50 Philips TLOl lOOW fluorescent 
lamps. The irradiancc was 4.1 mW cm-2 and was determined as for the UV6 
lamps. 
Group D patients received PUVA in a Waldmann 6000 cabinet incorpo-
rating 62 Sylvania FR74T12 fluorescent lamps (UVB = 0.2 mW cm-2 , 
UVA = 11.7 mW cm- Z). Irrad iance was monitored using a Waldmann 
§ Van Weelden H. van der Leun JC: Improving the effectiveness of 
phototherapy for psoriasis (abstr) . Br J Dennatol 111 :484, 1984. 
Mean Number Mean Total UV Dose Mean Total 
of Treatments at at Sample Point Number of Mean Total 
Sample Point During Therapy Treatments UV Dose 
(±SEM) (J",,- z ± SEM) (±SEM) (J,m -2 ± SEM) 
N/N N/A N/A N/A 
11.4 ± 1.8 1.8 ± 0 .3 18.9 ± 2.3 5.5 ± 1.3 
11.7 ± 0.5 8.0 ± 0.8 21.5 ± 1.S 19.2 ± 2.7 
7.0 ± 0.3 21.6 ± 4.0 15.5 ± 1.5 88.6 ± 18.1 
N/A N/A N/A N/A 
13.0 ± 1.1 3.4 ± 0.6 16.5 ± 0.5 6.3 ± 1.3 
PUVA mcter calibrated at the Regional Medical Physics Departmcnt, Dur-
ham. All patients had their minimal photo toxic dose determined, and the 
first irrad iation dose was 70% of this. Treatment was then given twice 
weekly with 40% incremental doses (l ess in case of erythema) at each visit 
until minimal res idual activity was achieved (15 - 20 treatments). 
Preparation of Peripheral Blood Mononuclear Cells (PBMC) and 
Phenotyping PEMC were isolated by centrifugation on lymphopague 
(Nyegard Ltd, Oslo, Norway). The cells were washed three times and sus-
pended in RPMI 1640 supplemented with antib iotics (27] plus 10% fetal calf 
serum (tissue culture medium) at 4 X 106 1111- 1• 
The method for phenotyping ofPBMC using a Coulter EPICS "C" flow 
cytometer has been described previously [27]. The cells were stained with 
murine monoclonal antibodies to COla, CD3, CD4, CD8 (Dakopatts, 
High Wycombe, UK), CD56, CD57 (Beckton-Dickinson, California), and 
pan MHC class II (DP, DR, DQ: DA6.231, a gift from Dr K. Guy) . An 
irrelevant antibody was used to determine the background non-specific 
staining, which was set to approximately 1 % of the total histogram. Data 
were initially collected on a two-parameter histogram measuring forward 
light scatter. Bit maps were drawn atound both the lymphocyte and the 
monocyte/large granular lymphocyte populations and the percentage of 
cel ls exhibiting fluorescent levels higher than background were recorded for 
these rwo populations independently. 
NK Cell Assay K562 cel ls were employed as targets in all experiments 
[28]. One million cel ls were labeled with 100 ~Ci sodium chromate (SICr, 
Amersham International Ltd, England) for 4 h at 37"C. They were washed 
three times in 0.01 M phosphate-buffered sa line, pH 7.2, suspended in tissue 
culture medium at 105 cel ls ml- I , and plated at 100 pI/well in round-bot-
tomed microtiter plates (Falcon, Becton Dickinson, Oxford, U.K) . Dou-
bling dilutions of l)BMC were carried out in tissue-culture medium and 
100 III of each dilution added to quadruplicate wells resulting in effector-to-
target-cell ratios from 40: 1 to 1.25 : 1. Spontaneous S1Cr release was deter-
mined by adding 100 It! tissue-culture medium to quadruplicate wells and 
maximum release by adding 100 III 2% acetic acid to guadruplicate wells. 
The plates were incubated for 18 h at 37 ' C in 5% CO2 in a humidified 
incubator, then spun at 300 X g for 5 min before removing 120 pI superna-
tant for determination of counts per minute (CPM) using a Packard liquid 
scinti llation counter. The SEM at each ratio was always less than 10% of the 
mean value. Percent specific slCr release was determined by 100 X ((test 
CPM - spontaneous CPM)/(maximum CPM - spontaneous CPM)]. 
Uroeanie Acid (UCA) TrallS-UCA was purchased from Sigma (Poole, 
Dorset). Cis-UCA was prepared and purified after UV irradiation of a solu-
tion of tralls-UCA as already described [29]. Cis- and trallS-UCA were dis-
solved in phosphate-buffered saline at concentrations of 10- 1 M and 
10- 2 M, respectively, and serial tenfold dilutions to 10- 8 M carried out in 
phosphate-buffercd saline. Ten microliters of each di lution was added to 
0.5 ml PBMC at lO-s cells ml- I. In addition 100 III of lO- 1 M cis- or 
10- 2 M trallS-UCA were added to 0.4 ml PBMC at 1.25 X 105 ml- I • One 
hundred microlitcrs UCA-treated PBMC were then added to the wells of a 
microtiter plate and 15 min later 100 III labeled target cells added at an 
effector: target cel l ratio of 40: 1. This resulted in a final concentration of 
cis-U CA of 10- 2 to lO- IO M, and Irmls-UCA of 10- 3 to 10- 10 M. Target 
cells were also incubated alone with the UCA isomers. 
Statistical Analysis Differences in NK cell activity of patients were de-
termined by Wilcoxon test or Student t test, where appropriate. 
RESULTS 
NK CeJl Activity in Normal Subjects and Patients with 
Psoriasis Before any treatment cOl11m enced, all 23 patients with 
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Figure 1. The effect of therapy on NK ce ll activity in patients with psoriasis and normal subjects. Psoriasis patients receiving coal tar dressing had samples 
taken on two occasions, before (0) and during (6 ) treatment (a). Assays were performed before (0) , during (6 ), and after (0) broad-band U V6 (b) , narrow band 
TLO l (c), or PUVA (d) th erapy of psorias is patients. N ormal subjects, receiving no treatment, had samples taken on two occasions 4 weeks apart (e, 0 and 6 ). 
Norm al subjects were assayed before (0), dunng (6 ), and after (0 ) UV6 therapy ([). T he points represent the mean offive patients in (a) , six in (b-d), and four 
in (e,J). The SEM shown for each group prior to treatment was approximately the same on subsequent occasions (error bars). 
psorias is and 11 normal subjects detailed in T able I were tested for 
NK cell ac tivity. A comparison of the two groups showed no statis-
tical difference at any effector : target cell ratio. For example, at an 
effector: target cel l ratio of 40 : 1, NK cell activity of normal volun-
reers was 52.2 ± 5.4 (mean ± SEM) compared w ith psoriatics 
64.1 ± 4.2 (p = 0.11, Wilcoxon rank sum tes t) . 
Effect of Therapy on NK Cell Activity in Normal Subjects 
and Patients with Psoriasis All patients showed a marked clini-
cal improvement (to at least minimal residual activity) in the degree 
of p sorias is irrespective of the treatment used. It shou ld be noted 
tha t , although a set of samples was collected after 4 weeks of ther-
apy, in most instances patients req uired 6 weeks of UV therapy to 
ach ieve complete or almost complete clearance of psorias is. 
Figure 1 illustrates the mean NK cell activity before, durin g, and 
after therapy in all subj ects. Coal tar therapy (group A) had no 
significant effect on NK cell activity (Fig 1a). Patients receiving 
broad-band UV6 treatment (group B) showed no significant alter-
atio n in NK cell activity after 4 weeks of th erapy (Fig 1 b) . However, 
there was some reduction in activity 4 weeks after the las t treatment 
in five of the six patients. This reduction was statistically significant 
for the group at all effector : target cell ratios (p = 0.046, Wilcoxon 
signed-ranks test) . Group C patients, receiving narrow-band TL01 
therapy, showed a marked depression in NK cel l ac tivity after 4 
weeks of therapy (Fig·l e); for example, the mean value (± SEM) for 
the group fel l from 66.8 ± 7.1 to 42.0 ± 6.6 at effector : target ce ll 
rat io of 40 : 1. This reduction was statistically significant at all effec-
ror: target cell ra tios (p = 0.028, Wilcoxon signed ranks tes t) . Four 
weeks after th e last irradiation the mean NK value fo r group C had 
recovered significantly, for example, to 50.9 ± 7.0 at effec-
tor: target cell ratio of 40 : 1 (p = 0.043, Wilcoxon signed-ranks 
tes t) . However, it sti ll remained signifi cantly depressed compared 
with the original value prior to irradiation in five of six patients 
(p = 0.043, Wilcoxon signed-ranks tes t) . Samples were collected 
from two of the patients a fur ther 4 weeks later, i.e., 8 weeks after 
the last irradiation. NK cell activi ty was again increased and had 
almost returned to the original value. A similar pattern was observed 
in the six patients receiving PUVA therapy (group D , Fig Id) . 
Following 4 weeks of therapy, all exhibited a marked reduction in 
NK cell activity; for example, at effector : target cell ratio of 40 : 1 
the activi ty fel l from a mean (± SEM) of 76.4 ± 6.1 to 51 .6 ± 8.0. 
The reduction was statistically significant at all effector: target cell 
ratios but more so if the ra tio was less than 40 : 1 (p = 0.046 at 
effector : target cell ratio of 40 : 1, and p = 0.028 at effector: target 
cell ratio less than 40: 1). Four weeks after the last treatment th e 
activity had recovered but it remained significa ntly suppressed rela-
tive to the original values at effector : target cell ratios less than 40 : 1 
(p = 0.028, Wilcoxon signed-ranks test) . T hree patients had their 
NK cell activi ty assessed a further 4 weeks later w hen it had almost 
returned to normal. 
Two groups of normal subj ects were also analyzed. The first, part 
of group E, consisted of four individuals w ho received no trea tment. 
The second , group F, consisted of four individuals who received a 
course ofuV6 identica l to that rece ived by the psorias is patients in 
group B, except th at only their arms were irradiated. Figure l e 
shows that there was no flu ctuation in NK cell activity in the group 
E subjects, w hereas Fig 1f demonstra tes th at four weeks of UV6 
th erapy had no significant effect on N K cell activity in group F 
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subjects. However, 4 weeks after the last irradiation NK cell ac tivity 
was suppressed in three individuals. This suppression did not reach 
statistical significance (p > 0.05 , paired sa mple t test). 
Phenotyping PBMC from all the normal subjects and psoriasis 
patients were stained with monoclonal antibodies aga inst CDla, 
CD3, CD4, CD8, CD57, and MHC class II antigens. There was no 
difference in any of the markers between normal subjects and pa-
tients, and no significant alteration of the markers occurred as a 
resu lt of therapy (data not shown). 
In addition to these antibodies, a furth er monoclonal against 
CD56 was employed to determine th e number of NK cells present 
in three patients in group C and four in group D. In the population 
of cells gated to include large granular lymphocytes and to exclude 
small er ce ll s, there was a reduced percentage of CD56+ cells during 
th erapy that rose afte r therapy had fini shed [% CD56+ cells before 
th erapy = 77.0 ± 6.5 (mean ± SEM), during therapy = 22.4 ± 
3.9, after therapy = 59.7 ± 8.3] . 
Effect of UCA Isomers on NK Cell Activity In Vitro The 
resu lts above indicate that UV irradiation i"1 Ilivo suppresses NK cell 
activity and the following experiments were undertaken to deter-
mine the effects of UCA on NK cell activity ill vitro. Because the 
co ncentrations of UCA isomers used were relatively high, various 
tests were carried out to ensure that the isomers were not toxic. In 
the first place, on four separate occasions, UCA isomers ranging 
from 10- 2 to 10- 10 M were added to wells containing labeled target 
cell s, which were then incubated for 18 h and the supernatant as-
sayed for release of 5l Cr. No alteration in background release of5 I Cr 
occurred at any concentration of cis or tralls-UCA. Secondly, effec-
tor cell s were incubated with UCA isomers for 18 h and the number 
of viable cells determined by trypan blue exclusion. This was always 
between 90 and 100%. Thirdly, the effector cells were incubated for 
18 h with 10- 3, 10- 6 , or 10-9 M cis- or tralls-UCA and then stained 
overnight with propidium iodide. The number of cells in the S + 
G2M stage of cell division were quantitated by flow cytometry using 
the S-Fit DNA analysis programme (Coulter Electronics Ltd., 
Luton, U.K.). Approximately 18% of cells were in S + G2M, and 
this value was not altered by the presence of UCA isomers. 
The rercentage suppression of NK cell activity induced by a 
range 0 concentrations of cis-UCA in vitro at an effector: target cell 
ratio of 20: 1 was determined for 12 subjects; seven normal volun-
teers and five untreated patients with psoriasis. Cis-UCA had the 
same effect on PBMC in all of these subjects and Fig 2a represents 
the mean suppression ofNK activity in these individuals. The effect 
of trans-UCA was measured in four normal subj ects in the same 
manner (Fig 2b). Treatment with cis-UCA resulted in a dose-depen-
dent suppression ofNK cell activity that was statistically significant 
at concentrations between 10- 2 and 10- 4 M. Tral/S-UCA was 
slightl y suppressive at higher concentrations but this was minimal 
in comparison with cis-UCA and was not statistically significant. 
Finally the effect of UCA isomers on the function of lympho-
cytes other than NK cells was examined. A lymphoproliferation test 
was carried out in which UCA isomers, in concentrations similar to 
those used in th e NK assay, were added to quintuplicate wells con-
taining PBMC together with sub-optimal concentrations of con-
canavalin A (1 .5 pg/ml) or HSV antigen (0.1 plaque forming unit/ 
cell , UV inactivated), as already outlined [27]. The experiment was 
done on two separate occasions using PBMC from two healthy 
donors known to be HSV carriers. In both cases, neither UCA 
isomer had any consistent or dose-dependent effect on lymphopro-
liferation (data not shown). 
DISCUSSION 
Suppressed NK ce ll activity has been reported in patients with gen-
eralized I?ustular psoriasis and, to a lesser extent, with psorias is vul-
garis [30J . In contrast, Hunyadi el al [31 ] found normal NK cell 
activity in a group of subjects with chronic plaque psorias is. Our 
study incl uded 20 patients with chronic plaque psoriasis and three. 
with guttate psoriasis. No sign ificant difference in NK cell activity 
was observed in comparison with eleven normal hea lthy subjects. 
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Figure 2_ The effect of cis-UCA (a) and lralls-UCA (b) on NK cel l activity 
ill Ililro. a represents the mean ± SEM of 6-11 subjects at each UCA concen-
tration and b represents the mean ± SEM of four subjects .• p < 0.05 and 
•• p < 0.01 compared with the mean of the same individuals with no UCA 
added, paired sample t test. 
Coal tar treatment as well as three established UV irradiation 
regimens used in the management of psoriasis caused a marked 
improvement in the severity of psoriasis in all cases. However, only 
patients receiving UV exhibited any suppression in NK ce ll activity. 
This suggested that the modulation in NK cell function resulted 
from UV irradiation and was not secondary to clinical improve-
ment. 
Suppressed NK cell activity was found in all patients after 4 weeks 
ofTL01 (group C) or PUVA (group D) therapy. Four weeks after 
treatment had stopped, NK cell activity had begun to recover al-
though in neither group had it regained its initial level. The kinetics 
of NK cell modulation were different when the broad-band UVB 
(UV6) lamp was used (group B). In this case, there was no signifi-
cant change in NK cell activity following 4 weeks of therapy but 
suppression had occurred 4 weeks after the completion of the course 
(Fig Ib). It is possible that the suppression ofNK cell activity by UV 
irradiation may be dose dependent. As the TL01 and UVA sources 
do not emit the highly erythemogenic wavelengths, patients re-
ceived higher doses ofUV in a short period of time compared with 
group B (Table I) . Furthermore, this is suggested by the results from 
group F (normal subjects undergoing broad-band UVB irradiation 
of their arms only) as, although a reduction in NK cell activi ty was 
recorded in most individuals 4 weeks after the last irradiation, it did 
not reach statistical significance (Fig If) . A dose-dependent sup-
pression in NK cell activity followin g solarium exposure has been 
reported [32] . In that study normal subjects were irradiated with 
approximately one minimal erythemal dose for 2,6, or 12 consecu-
tive days. At least six consecutive days of exposure were required to 
induce suppression ofNK cell activity and the suppression was more 
pronounced following 12 d. Those patients who received 12 whole 
body exposures sti ll demonstrated suppressed NK cell function 21 d 
after the last irradiation. Another study examined the effects of 
PUVA therapy on NK cells in a group of patients with a number of 
skin disorders, 50% of whom had psoriasis vulgaris [17] . A reduc-
tion in NK cel l activi ty was observed during therapy although this 
tended to return to normal at the higher effector: target cell ratio, if 
the therapy was continued beyond 25 irradiations. 
In addition to the total UV ~ose, it is possible that the incident 
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wavelengths of UV are important. In this respect Hersey et aJ [33] 
reported that 12 1-h exposures to sunli ght in a 2-week period had 
only a minimal effect on NK cell activity. However, further studies 
revealed th at 2 weeks of irradiation with so larium lamps resulted in 
suppressed activity [34]. The ratio of UVA to UVE emitted by 
solarium lamps was estimated to be three times higher than that of 
natu ral sunlight, and it was shown that the suppression of NK cell 
function still occurred even if wavelengths in the UVE range were 
excluded [16,35]. Hence it was concluded that UVA wavelengths 
(320 -400 nm) were solely responsible for the effects on NK cells. 
However, our present studies do not support this view because the 
TL01 source that emits narrow-band UVE (311-313 nm) pro-
duced suppression of NK cell activity during therapy . hi lIitro, 
shorter UV wavelengths have been demonstrated to cause more 
suppression of NK cell activity than longer wavelengths [14]. 
Hersey et aJ [35] reported minimal changes in the number of 
circulating CD16+ ce ll s as a result of irradiation and we observed no 
change in CD57+ cells, suggesti ng th at the total number of circulat-
ing NK cel ls remains unaltered . However preliminary tests indi-
cated that the percenta ge of large granular lymphocytes expressing 
CD56 was reduced in patients receiving TL01 or PUVA therapy 
and this correlated with reduced NK cell activity. CD 56 is thought 
to be an activation marker expressed on NK cells and is found on 
very fe w T cells [36]. 
The mechanism whereby UV irradiation affects NK function is 
unknown. Possibly there may be a direct effect on NK cel ls as they 
circul ate through the dermal capillaries th at results in permanent 
functional damage. The recovery of activity may then be dependent 
on the regenera tion of cells from the bone marrow. It is also possible 
that there may be modulation by another cell type, such as mono-
cytes [37] or NK cells themselves [38] . Alternatively a soluble medi-
ator may be released from epidermal cells on irradiation that enters 
the circu lation and affects NK cell function. Kim et aJ [39] and 
Brodie and H alliday [40] have reported soluble suppressive factors 
in murine serum foll owing UV irradiation that are potential candi-
dates. Prosta glandins, induced by UV exposure, are other possibili-
ties as they have been shown to inhibit NK cell activity [41] . III I/itro 
epidermal cells release an interl eukin-1 -like factor that augments 
NK cell activity. This is called epidermal cel l-derived NK cell 
activity- augmenting factor and may be relevant ill lI illO [42] . Fi-
nally, there may be altered regulation of the function of other cells 
through modified cytokine secretion by NK cel ls themselves. 
One furth er factor that merits consideration is cis-UCA, formed 
in th e epidermis from trans-UCA on UV irradiation. W e have 
shown in the present study that cis-UCA treatment ill lIilro resulted 
in a dose-dependent suppression ofNK cell activity , whereas trallS-
UCA had little effect. The concentration of cis-UCA required to 
modul ate the activity was relatively high (10- 2 to 10- 4 M) . How-
ever, IrallS-UCA is present in considerable amounts in the human 
epidermis (about 8 Jlg cm- 2 [43]) and, on UV exposure, up to ap-
proximately 60% converts to th e cis-isomer in a dose-dependent 
fash ion. W e have shown that cis-UCA is present in suction blister 
flu id and it is reta ined in this compartment for at least 4 weeks after 
irradiation [44] . Strenuous efforts were made to ensure that th e 
conditions were not toxic for the effector or target cells in the NK 
assay. Trypan blue exclusion and propidium iodide staining indi-
cated no demonstrable cell death and PEMC were not suppressed in 
a Iymphopro liferation test. 
Although the second messenger system involved in NK cell lys is 
remains to be identified, an increase in intracel lular Ca++ is asso-
ciated with NK cell activation and this is thought to be regulated by 
cyclic adenosine monophosphate [45]. Significantly cis-UCA has 
been shown recently to down-regulate the induction of cyclic aden-
osi ne monophosphate by tralls-UC A or histamine [46] and there-
fore it is possible that cis-UCA may down-regulate the second mes-
senger system of the· NK cell. 
In this study NK cell activities of normal subjects and psoriatic 
patients did not differ before treatment, they responded in a similar 
fashion to UV6 therapy, and they were affected by cis-U CA ill lI il ro 
to the same extent. Thus it is reasonable to assume that the modula-
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tions noted are relevant to NK cells in general and are not confined 
to psoriasis. 
Finally, because NK cells are thought to playa major role in 
tumor surveillance, it is of concern that currently employed pho-
totherapies result in significa nt suppression of NK cell function 
during treatment with some UV sources and for several weeks fol -
lowing treatment with all UV sources. 
JWG Ivas slIpported by a stlldelltship fro lll the Medica! Resea rch COllllci!. 
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